1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 12 Hits
  • 検索条件 : 絞込み (MeSH = Brain Neoplasms / immunology)
生物種 リソース名 タイトル
遺伝子材料 pMFGmGM-CSF (RDB01438) , pMFGmIL2 (RDB01441) , pMFGmIL3 (RDB01442) , pMFGmIL4 (RDB01443) , pMFGmIL6 (RDB01444) , pMFGmIL7 (RDB01445) , pMFGmTNF alpha (RDB01449) , pMFGmLT (RDB01451) , pMFGmG-CSF (RDB01452) , pMFGmLIF (RDB01456) Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
ヒト・動物細胞 B16 Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
ヒト・動物細胞 YAC-1(RCB1165) Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
ヒト・動物細胞 A172(RCB2530) Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models.
ヒト・動物細胞 Glioma immunotherapy with combined autologous tumor cell and endothelial cell vaccine in vivo.
ヒト・動物細胞 B16 Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
ヒト・動物細胞 YAC-1(RCB1165) Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.
ヒト・動物細胞 CCF-STTG1(RCB1977) Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
ヒト・動物細胞 U251(RCB0461) Apoptosis of human glioma cells in vitro and in vivo induced by a neutralizing antibody against human basic fibroblast growth factor.
遺伝子材料 pRx nZ ires Neo (RDB01699) , pRxZiN (RDB01880). Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy.
遺伝子材料 pCAEGFP (RDB03956) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
ヒト・動物細胞 HFWT(RCB0665) Autologous natural killer cell therapy for human recurrent malignant glioma.